Patent · US Active

Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

US11491148B2 · kind B2 · utility

0Cited by

88References

19Claims

0Family size

Assignee

Janssen Sciences Ireland Unlimited Company · IE

Inventors

Bart Rudolf Romanie Kesteleyn · Berlare, BE
Jan Martin Berke · Düsseldorf, DE
Erwin Coesemans · Nijlen, BE
Sandrine Céline GROSSE · Turnhout, BE
Edgar Jacoby · Beerse, BE
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Stefaan Julien Last · Lint, BE
Wim Gaston Verschueren · Berchem, BE
Michel Obringer · Ostwald, FR
Christelle Catherine Cecile DOEBELIN · Illkirch-Graffenstaden, FR

Key dates

Filing date	May 5, 2020
Grant date	Nov 8, 2022
Priority date	—
Expiry date	May 6, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The application relates to amide derivatives of formula (I), processes for their preparation, pharmaceutical compositions, and their uses, more particularly their uses in treating chronic hepatitis B virus (HBV) infection:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.